It has been more than six months since the outbreak of the novel coronavirus emerged in Wuhan, China and the contagion has infected more than 12 million people across the world and claimed 5,71,660 lives. As of now, there are close to 155 vaccines in several stages of trials to combat the spread of the contagious virus and 22 of them have reached the clinical trial stage.
While we all know about the global frontrunners in the race develop the vaccine including Moderna, CanSino, Inovio, BioNtech, Pfizer and AstraZeneca, back home AIIMS (All India Institute of Medical Sciences) Patna, is all set to begin human trials of India’s first coronavirus vaccine, Covaxine.
